Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Malvern Highlights New Analytical Instruments for Biopharma at The Bioprocessing Summit

Published: Tuesday, August 13, 2013
Last Updated: Tuesday, August 13, 2013
Bookmark and Share
Company showcases new analytical tools in Boston from 19-23 August 2013.

Malvern Instruments is showcasing new analytical tools for biopharmaceutical applications on its exhibition booth at The Bioprocessing Summit in Boston from 19-23 August 2013

In July the company has launched two new systems, the Viscotek SEC-MALS 20 and the Viscosizer 200, for the characterization of biological materials.

These join Malvern’s rapidly growing range of analytical instruments, which also includes the Zetasizer Nano ZSP, for use in pre-formulation and formulation studies and for the wider characterization of proteins and other macromolecules.

Viscotek SEC-MALS 20 is the new addition to Malvern’s range of detectors for size exclusion chromatography (SEC) and extends its family of light scattering detectors for measuring the absolute molecular weight of proteins, macromolecules and polymers.

This range now includes cost-effective options with unsurpassed performance for every type of light scattering detection - low angle, right angle and multi angle - allowing Malvern to answer every SEC challenge with the most appropriate technology.

By combining a Viscotek SEC detector or system with the powerful and intuitive OmniSEC software, it is possible to characterize: absolute molecular weight without extrapolation or correction, molecular size and intrinsic viscosity, as well as investigate branching, structure and aggregation in a single GPC/SEC experiment.

Malvern’s Viscosizer 200 is the latest product to reach commercialization as a result of Malvern’s highly focused Bioscience Development Initiative.

Designed primarily to help solve key analytical challenges at the preformulation stage of pharmaceutical, and particularly biopharmaceutical, development, the automated Viscosizer 200 delivers viscosity and molecular size data on UV-active samples, using volumes of less than 10 µL.

Measuring viscosity early in the development of biological formulations is critical in order to reduce the number of candidate failures during subsequent stages of development.

The Viscosizer 200 has been engineered to give automated, high throughput measurements on extremely low and recoverable sample volumes, and to operate at high sample concentrations under formulation conditions.

Launched last year, the Zetasizer Nano ZSP is the top of the range addition to the established Zetasizer family of light scattering systems. It brings unique performance specifications for both size and zeta potential measurement, one of the most significant applications for which is the measurement of the zeta potential, or electrophoretic mobility, of proteins.

This process is further simplified by the inclusion of a new protein mobility measurement type in the software that controls data acquisition, guiding the user through the measurement, and assesses and reports on data quality.

Protein mobility is one property that has been identified as a promising indicator of formulation stability, viscosity, and behavior.

Therefore, the new protein mobility measurement provided by the Zetasizer Nano ZSP, in combination with the Diffusion Barrier Technique for sample introduction, ensures that the measured electrophoretic mobility is that of the protein, rather than any aggregates present.

Malvern specialists will be on hand throughout the show and look forward to welcoming visitors to the booth.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Malvern Signs Exclusive Agreement with Affinity Biosensors
Agreement to distribute Affinity Biosensors’ Archimedes system extends Malvern Instruments’ biopharma solutions.
Tuesday, March 05, 2013
Malvern Specialist Discusses Light Scattering Techniques at BioProcess International Europe 2011
Dr Hanna Jankevics will present a poster at the 7th annual BioProcess International Europe conference in Nice (France).
Thursday, April 14, 2011
Malvern Specialist Tests Sensitivity Limits of Dynamic Light Scattering
Malvern’s Zetasizer Nano systems use light scattering techniques to measure the hydrodynamic size, zeta potential and molecular weight of proteins and nanoparticles.
Wednesday, October 06, 2010
Scientific News
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Novel Proteins Linked to Huntington's Disease
University of Florida Health researchers have made a new discovery about Huntington's disease, showing that the gene that causes the fatal disorder makes an unexpected "cocktail" of mutant proteins that accumulate in the brain.
Enzyme Critical to Maintaining Telomere Length Discovered
New method expected to speed understanding of short telomere diseases and cancer.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos